Trial Profile
A Phase III Double-blind, Randomised, Placebo-controlled Study of the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Oct 2021
Price :
$35
*
At a glance
- Drugs Idebenone (Primary)
- Indications Friedreich's ataxia
- Focus Adverse reactions
- Acronyms MICONOS Extension
- Sponsors Santhera Pharmaceuticals
- 20 Nov 2014 New trial record